2011 Final Programme Booklet

Sinupret®
The medicine for the nose
loosens phlegm
unblocks the nose
clears the head
Bronchipret®
The cough medicine
Sinupret® forte | Composition: 1 coated tablet of Sinupret forte contains as Active pharmaceutical ingredients: European Vervain (herb), powdered 36 mg; Gentian (root), powdered 12 mg; Common Sorrel (herb), powdered
36 mg; European Elder (fl ower), powdered 36 mg; Primula fl ower with calyx, powdered 36 mg. Excipients: Glucose syrup 2.712 mg, Lactose monohydrate 48.490 mg, Sucrose 122.754 mg, Sorbitol 0.444 mg, Dextrin,
Eudragit E 12.5; gelatine; glucose syrup; potato starch; lactose monohydrate; maize starch; magnesium oxide, light; montan glycol wax; sodium carbonate; polyvidone; castor oil, refi ned; sucrose; shellac; colloidal
anhydrous silica; sorbitol; stearic palmitic acid; talc; quinoline yellow, E 104, aluminium salt; indigo carmine, E 132, aluminium salt; aluminium oxide; calcium carbonate (E 170); titanium dioxide (E 171). Therapeutic
indications: In acute and chronic infl ammation of the paranasal sinuses. Contraindications: Sinupret forte should not be taken with known hypersensitivity to the active substance(s) or to any of the excipients of Sinupret
forte. Special warnings and precautions for use:There are no suffi cient studies on the use of Sinupret forte in children under the age of 12 years. Therefore, Sinupret forte should not be used in children under
the age of 12 years. Patients with the rare hereditary fructose intolerance, galactose intolerance, lactase defi ciency, glucose-galactose malabsorption or sucrose-isomaltase defi ciency should not take Sinupret forte.
It is pointed out to the patient in the package leafl et that if symptoms last longer than 7 – 14 days or recur periodically a physician is to be consulted. Pregnancy and lactation: Like all medicines, Sinupret forte should
only be used during pregnancy and lactation after strict diagnosis. Undesirable effects: uncommon: Gastrointestinal complaints (for instance stomach pain, nausea); Rare: Hypersensitivity reactions of the skin (skin
rash, reddening of the skin, itching) as well as severe allergic reactions (angioedema, dyspnoea, swelling of the face) are rare. • Bronchipret® Syrup TE | Composition: 10 g (equalling 8.85 ml) Bronchipret Syrup TE contain:
1.50 g fl uid extract derived from thyme herb (1:2-2.5); extracting agent: ammonia solution 10 % (m/m): glycerol 85 % (m/m): ethanol 90 % (V/V): water (1:20:70:109) 0.15 g fl uid extract derived f rom ivy leaves (1:1); extracting
agent: ethanol 70 % (V/V); The medicinal product contains 7 % (V/V) alcohol. List of excipients: Citric acid monohydrate, purifi ed water, potassium sorbate (Ph. Eur.), maltite solution. Note for diabetics: 1 single dose
of Bronchipret Syrup TE (5.4 ml) contains an average of 0.18 carbohydrate exchange units (CEU). Therapeutic indications: For the treatment of acute bronchitis with cough being a symptom of a cold, characterized by
excessive mucous congestion. Contraindications: Do not take Bronchipret Syrup TE in case of a known hypersensitivity towards ivy, thyme or other Lamiaceae (Labiatae), birch, mugwort, celery or any other component
of the medicinal product. Undesirable effects: Rare: hypersensitivity reactions with skin rash. Furthermore, hypersensitivity reactions with dyspnea, hives and swellings in face, mouth and/or pharyngeal region may occur.
Occasionally: gastrointestinal complaints such as cramps, nausea and vomiting have been observed. Special warnings and precautions for use: The package leafl et informs the patient as follows: Consult a doctor if
complaints persist for more than a week or if symptoms such as dyspnea, fever or purulent and bloody sputum are observed. Precautions for use in children: Bronchipret Syrup TE should not be adminstered to children
younger than 1 year. The medication contains 7 % (V/V) alcohol. Patients with the rare hereditary fructose intolerance should not take Bronchipret Syrup TE. Pregnancy and lactation: There are no adequate data available
on the use in pregnant and lactating women. • Tonsipret® tablets | Composition: 1 tablet Tonsipret tablets contains: Capsicum annuum Dil. D3 75,0 mg, Guaiacum Dil. D3 75,0 mg, Phytolacca americana Ø 50,0 mg. Further
excipients: Lactose monohydrate 250.0 mg, List of excipients: Potato starch, Lactose monohydrate, Magnesium stearate. Note for diabetics: 1 Tonsipret tablet contains 0,02 carbohydrate exchange units. Therapeutic
indications: Homeopathic drug for infl ammatory diseases of the pharynx. The areas of application can be derived from the homeopathic drug pictures. These include: Acute infl ammation of the throat or tonsils (tonsillitis).
Contraindications: Hypersensitivity to the active substances or to any of the excipients. Special warnings and precautions for use: Due to its lactose content this medicinal product is unsuitable for patients suffering
from the rare hereditary galactose intolerance, congenital lactase defi ciency or glucose-galactose malabsorption. Since suffi ciently documented experience on use on infants is not available, the drug should not
be used on children under 1 year of age. Undesirable effects: Rare: cases nausea and gastric complaints; Allergic skin reaction. Note: On using a homeopathic drug, the existing complaints may temporarily exacerbate
(homeopathic aggravation). In this case you should stop taking the drug and consult with your doctor. Pregnancy and lactation: Since suffi ciently documented experience on use during pregnancy and lactation is not
available, the drug should be used upon consultation with a doctor only. • Imupret® Oral Drops | Composition: 100 g Imupret Oral Drops contain: 29 g of an alcoholic aqueous extract (extracting agent: ethanol 59 % (V/V)
made from Radix Althaeae 0.4 g, Flores Chamomillae 0.3 g, Herba Equiseti 0.5 g, Folia Juglandis 0.4 g, Herba Millefolii 0.4 g, Cortex Quercus 0.2 g, Herba Taraxaci 0.4 g. Contains 19 % (V/V) alcohol. List of excipients: Imupret
Oral Drops contain 19 % (V/V) alcohol. Note for diabetics: Imupret Oral Drops contain no relevant amounts of carbohydrate exchange units (CEU). Therapeutic indications: frequently recurrent and chronic respiratory
infections especially tonsillitis. Contraindications: Do not take Imupret Oral Drops in case of hypersensitivity to the active substances or to any of the excipients, and if known allergy to composite fl owers. Undesirable
effects: Rare: Allergic skin reactions. Interaction with other medicinal products and other forms of interaction: There are no known interactions with other medicinal products. Pregnancy and lactation: There are no
adequate data on the use of this medicinal product in pregnant and breast-feeding women. Ask your doctor for advice before taking this medicine. Stand 11|10
BIONORICA SE | 92308 Neumarkt | Germany
Mitvertrieb: PLANTAMED Arzneimittel GmbH | 92308 Neumarkt | Germany
relieves coughing
heals infl ammation
clears the bronchial passages
Bionorica SE booth n11
Please also visit our symposium
“New developments in treatment of infectious and
allergic respiratory diseases with phytopharmaceuticals“
24 June 2011 | 08:00 – 09:00 am | Parallel Hall 2
Tonsipret®
The throat medicine
reduces soreness
soothes the throat
purely plant-based
Imupret®
The immune system
defence medicine
slows down infection
strengthens the immune system
protects against recurrent infections